Multiple Manufacturers

LABETALOL HCL

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Multiple Manufacturers

Labetalol Hcl HCPCS:

J1921

HCPCS Code Descriptor:

Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg

Category:

J Code

Labetalol Hcl NDCs:

00143-9365-10, 00143-9366-10, 00143-9364-10, 00143-9363-10, 00641-6252-10, 00143-9623-01, 00143-9622-01, 00143-9320-01

Primary Type:

Cardiology

Generic/Specialty Status:

Multi-Source

Package Type:

Multiple

Route of Administration:

Intravenous

Labetalol Hcl CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have identified listing errors with the following NDCs:

00143-9622-01, 00641-6252-10, 00143-9363-10, 00143-9364-10, 00143-9366-10, 00143-9365-10

About Labetalol Hcl:

LABETALOL HCL is a medication manufactured by multiple manufacturers and aligned to the J Code: J1921. LABETALOL HCL is administered via the intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J1921 Added Date:

July 1, 2023

J1921 Effective Date:

July 1, 2023

J1921 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Labetalol Hcl billing and coding information.
Our team did not identify a source for Labetalol Hcl patient assistance information. Please reach out to our team if you feel that this is a mistake.
LABETALOL HCL prescribing information can be found at the link below:
Information regarding LABETALOL HCL’s side effects can be found at MedlinePlus